143 research outputs found
Deep learning analysis of the myocardium in coronary CT angiography for identification of patients with functionally significant coronary artery stenosis
In patients with coronary artery stenoses of intermediate severity, the
functional significance needs to be determined. Fractional flow reserve (FFR)
measurement, performed during invasive coronary angiography (ICA), is most
often used in clinical practice. To reduce the number of ICA procedures, we
present a method for automatic identification of patients with functionally
significant coronary artery stenoses, employing deep learning analysis of the
left ventricle (LV) myocardium in rest coronary CT angiography (CCTA). The
study includes consecutively acquired CCTA scans of 166 patients with FFR
measurements. To identify patients with a functionally significant coronary
artery stenosis, analysis is performed in several stages. First, the LV
myocardium is segmented using a multiscale convolutional neural network (CNN).
To characterize the segmented LV myocardium, it is subsequently encoded using
unsupervised convolutional autoencoder (CAE). Thereafter, patients are
classified according to the presence of functionally significant stenosis using
an SVM classifier based on the extracted and clustered encodings. Quantitative
evaluation of LV myocardium segmentation in 20 images resulted in an average
Dice coefficient of 0.91 and an average mean absolute distance between the
segmented and reference LV boundaries of 0.7 mm. Classification of patients was
evaluated in the remaining 126 CCTA scans in 50 10-fold cross-validation
experiments and resulted in an area under the receiver operating characteristic
curve of 0.74 +- 0.02. At sensitivity levels 0.60, 0.70 and 0.80, the
corresponding specificity was 0.77, 0.71 and 0.59, respectively. The results
demonstrate that automatic analysis of the LV myocardium in a single CCTA scan
acquired at rest, without assessment of the anatomy of the coronary arteries,
can be used to identify patients with functionally significant coronary artery
stenosis.Comment: This paper was submitted in April 2017 and accepted in November 2017
for publication in Medical Image Analysis. Please cite as: Zreik et al.,
Medical Image Analysis, 2018, vol. 44, pp. 72-8
Serial Morphological and Functional Assessment of Drug-Eluting Balloon for In-Stent Restenotic Lesions Mechanisms of Action Evaluated With Angiography, Optical Coherence Tomography, and Fractional Flow Reserve
ObjectivesThis study sought to elucidate the underlying mechanism through which drug-eluting balloons (DEB) restore coronary blood flow, by assessing the coronary vessel before, immediately after, and at 6-month follow-up with angiography, optical coherence tomography (OCT), and fractional flow reserve (FFR).BackgroundIn-stent restenosis (ISR) treatment remains challenging. Drug-eluting balloons have been shown to be a valid treatment option in several studies. These studies focused on efficiency of the device, whereas the mechanisms of action of DEB in ISR treatment have not been investigated.MethodsIn this prospective, single-center observational study, patients with ISR were treated with a second-generation DEB. Serial angiographic, OCT, and FFR measurements were performed before and after the procedure, as well as at 6-month follow-up.ResultsTwenty-five patients were assigned to DEB treatment, with an angiographic and device success of 100% and 92%, respectively. Late luminal loss was 0.01 ± 0.43 mm. Median percent changes [interquartile range] between pre-and post-procedure, and post-procedure and follow-up were, respectively: lumen volume 75.1% increase [43.7 to 115.0], and 8% increase [â14.0 to 25.8]; stent volume 23.7% increase [15.5 to 40.0], and â1.2% decrease [â6.9 to 5.9]; and neointimal volume â14.4% decrease [â29.2 to â9.5], and â15.8% decrease [â38.1 to 28.3]. The FFR gradient along the treated stent (difference in FFR between the distal and the proximal stent edge) was 0.37 ± 0.18 pre-procedure, 0.06 ± 0.04 post-procedure, and 0.05 ± 0.05 at follow-up. In all post-procedural OCT images, intrastent dissections were seen, which were sealed at follow-up OCT.ConclusionsDEB restore coronary blood flow by means of a short-term mechanical effect, causing an increase in lumen and stent volumes and compression of neointimal hyperplasia (with intra-stent dissections). Due to the local drug effect, patency persists and may even improve at follow-up, with further increase in lumen volume, decrease in neointimal volume, and complete sealing of neointimal dissections
Deep learning analysis of coronary arteries in cardiac CT angiography for detection of patients requiring invasive coronary angiography
In patients with obstructive coronary artery disease, the functional
significance of a coronary artery stenosis needs to be determined to guide
treatment. This is typically established through fractional flow reserve (FFR)
measurement, performed during invasive coronary angiography (ICA). We present a
method for automatic and non-invasive detection of patients requiring ICA,
employing deep unsupervised analysis of complete coronary arteries in cardiac
CT angiography (CCTA) images. We retrospectively collected CCTA scans of 187
patients, 137 of them underwent invasive FFR measurement in 192 different
coronary arteries. These FFR measurements served as a reference standard for
the functional significance of the coronary stenosis. The centerlines of the
coronary arteries were extracted and used to reconstruct straightened
multi-planar reformatted (MPR) volumes. To automatically identify arteries with
functionally significant stenosis that require ICA, each MPR volume was encoded
into a fixed number of encodings using two disjoint 3D and 1D convolutional
autoencoders performing spatial and sequential encodings, respectively.
Thereafter, these encodings were employed to classify arteries using a support
vector machine classifier. The detection of coronary arteries requiring
invasive evaluation, evaluated using repeated cross-validation experiments,
resulted in an area under the receiver operating characteristic curve of on the artery-level, and on the patient-level. The
results demonstrate the feasibility of automatic non-invasive detection of
patients that require ICA and possibly subsequent coronary artery intervention.
This could potentially reduce the number of patients that unnecessarily undergo
ICA.Comment: This work has been accepted to IEEE TMI for publicatio
Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
BACKGROUND: Anti-tumour necrosis factor alpha (TNFα) therapy is widely used in the management of Crohnâs disease (CD) and ulcerative colitis (UC). However, up to a third of patients do not respond to induction therapy and another third of patients lose response over time. To aid patient stratification, polygenetic risk scores have been identified as predictors of response to anti-TNFα therapy. We aimed to replicate the association between polygenetic risk scores and response to anti-TNFα therapy in an independent cohort of patients, to establish its clinical validity. MATERIALS AND METHODS: Primary non-response, primary response, durable response and loss of response to anti-TNFα therapy was retrospectively assessed for each patient using stringent definitions. Genome wide genotyping was performed and previously described polygenetic risk scores for primary non-response and durable response were calculated. We compared polygenetic risk scores between patients with primary response and primary non-response, and between patients with durable response and loss of response, using separate analyses for CD and UC. RESULTS: Out of 334 patients with CD, 15 (4%) patients met criteria for primary non-response, 221 (66%) for primary response, 115 (34%) for durable response and 35 (10%) for loss of response. Out of 112 patients with UC, 12 (11%) met criteria for primary non-response, 68 (61%) for primary response, 19 (17%) for durable response and 20 (18%) for loss of response. No significant differences in polygenetic risk scores were found between primary non-responders and primary responders, and between durable responders and loss of responders. CONCLUSIONS: We could not replicate the previously reported association between polygenetic risk scores and response to anti-TNFα therapy in an independent cohort of patients with CD or UC. Currently, there is insufficient evidence to use polygenetic risk scores to predict response to anti-TNFα therapy in patients with IBD
Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
Background: Thrombosis after liver transplantation is a leading cause of graft loss, morbidity, and mortality. Several known recipient- and surgery-related characteristics have been associated with increased risk of thrombosis after transplantation. Potential donor-related risk factors, however, remain largely undefined. Objectives: We aimed to identify risk factors for early post-transplantation thrombosis ('90Â days) and to determine the impact of early postoperative thrombosis on long-term graft and patient survival. Patients/Methods: A post hoc analysis was performed of an observational cohort study including all primary, adult liver transplantations performed between 1993 and 2018. Donor-, recipient-, and surgery-related characteristics were collected. Competing risk model analyses and multivariable regression analyses were performed to identify risk factors for developing early post-transplant thrombosis and graft failure. Results: From a total of 748 adult liver transplantations, 58 recipients (7.8%) developed a thrombosis after a median of 7Â days. Post-transplantation thrombotic events included 25 hepatic artery thromboses, 13 portal vein thromboses, and 22 other thrombotic complications. Donor history of smoking was independently associated with early postoperative thrombosis (odds ratio [OR] 2.42; 95% confidence interval [CI], 1.29-4.52). Development of early post-transplant thrombosis was independently associated with patient mortality (hazard ratio [HR] 3.61; 95% CI 1.54-8.46) and graft failure (HR 5.80, 95% CI 3.26-10.33), respectively. Conclusion: Donor history of smoking conveys a more than two-fold increased risk of thrombosis after liver transplantation, independent of other factors. Post-transplant thrombosis was independently associated with decreased patient and graft survival
Latent cytomegalovirus infection does not influence long-term disease outcomes in inflammatory bowel disease, but is associated with later onset of disease
Objectives: Cytomegalovirus (CMV) infection is common in the general population. CMV infection negatively affects disease course in transplant recipients and HIV patients. Whereas primary CMV infections may occur sporadically in seronegative patients, all seropositive patients with inflammatory bowel syndrome (IBD) are at risk for CMV reactivation due to the inflammatory mucosal and use of immunosuppressive medication. It is unclear whether latent CMV infection, and risk of reactivations, influences long-term disease outcomes. In this study, we aim to explore whether CMV infection affects disease outcomes in IBD patients. Methods: We performed a cross-sectional cohort study with 1404 patients with IBD from a single center. Clinical characteristics and disease outcomes were prospectively collected. We scrutinized CMV serology test results and performed additional CMV serology testing if serum was available. Results: Out of 699 IBD patients with CMV serology, 303 (43.3%) were seropositive, comparable to the general Dutch population. CMV seropositivity was associated with older age, longer IBD disease duration, non-Western origin, birth outside the Netherlands and a lower educational level (p-values â€.004). CMV seropositivity was not associated with more complicated long-term disease outcomes of IBD (p-values >.05). Seropositive patients presented with symptoms and were diagnosed at an older age compared to seronegative patients (p-values <.01). Conclusions: CMV seropositivity does not influence disease outcomes of IBD patients and seems to be associated with a delay in IBD onset. Guidelines regarding CMV screening in patients with IBD are currently based on a low level of evidence. These data support the recommendation that routine CMV serology measurement is not necessary in the clinical care of IBD
Environmental factors associated with biological use and surgery in inflammatory bowel disease
Background and Aim: While major efforts were made studying the complex etiology of inflammatory bowel disease (IBD) including environmental factors, less is known about underlying causes leading to the heterogeneous and highly variable course of disease. As cigarette smoking cessation is the best-known environmental factor with beneficial effect in Crohn's disease (CD), more exposome factors are likely involved. Further insights into the role of the exposome in heterogeneity of disease might not only further knowledge of underlying pathways, but also allow for better risk stratification. Methods: Seven hundred twenty-eight IBD patients completed the validated Groningen IBD Environmental Questionnaire, collecting exposome data for 93 exposome factors. Associations with disease course, that is, for need for surgery or biological therapy, were evaluated using univariate and multivariate-adjusted logistic regression modeling. Results: No significant associations were seen after Bonferroni correction. However, 11 novel exposome factors were identified with PÂ <Â 0.05. Two factors were associated with course of CD and ulcerative colitis (UC): beer (CD OR0.3/UC OR0.3) and cannabis (0.5/2.2). While in CD, carpet flooring (0.5) was associated with biological use, and four factors were associated with surgery: working shifts (1.8), appendectomy (2.4), frequent tooth brushing (2.8), and large household size (0.1). For UC, migrants more often required biologicals (10.2). Childhood underweight (3.4), amphetamine use (6.2), and cocaine use (4.8) were associated with surgery. Five factors were replicated. Conclusions: We identified 16 environmental factors nominally associated with biological use and surgery in established IBD. These new insights form an important stepping stone to guide research on biological pathways involved, risk stratification, tailor-made interventions, and preventive strategies in IBD
Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis
Objectives: To compare the outcomes of transfemoral ACURATE neo (NEO) and Sapien 3 (S3) patients in terms of device success and clinical safety outcomes using a propensity score analysis. Background: Differences in clinical outcomes between the latest-generation balloon-expandable S3 and self-expanding NEO in a âreal-world transfemoral TAVI populationâ are still unclear. Methods: We compared up to 6 months clinical outcomes using a propensity s
- âŠ